Annual report pursuant to Section 13 and 15(d)

Note 22 - Segment Information: Schedule of Segment Information (Details)

v3.20.1
Note 22 - Segment Information: Schedule of Segment Information (Details) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cannabis and Medical Marijuana Segment    
Net sales $ 158,614 $ 1,647,735
Operating income (loss) (796,232) 431,971
Interest income 23,561 83,398
Interest Expense 0 377
Total assets 1,572,998 4,571,778
Property additions 0 0
Depreciation, Depletion and Amortization, Nonproduction 0 0
Facilities Operations Related    
Net sales 4,167,858 3,633,798
Operating income (loss) 74,128 17,395
Interest income 10 4
Interest Expense 26,921 19,658
Total assets 1,646,867 1,228,783
Property additions 11,766 13,484
Depreciation, Depletion and Amortization, Nonproduction 11,333 12,493
Consolidation, Eliminations    
Net sales 0 0
Operating income (loss) (1,023,839) (1,036,796)
Interest income 84,542 84,803
Interest Expense (4,325) (2,628)
Total assets 1,746,712 2,292,102
Property additions 0 12,256
Depreciation, Depletion and Amortization, Nonproduction 11,780 8,269
Net sales 4,326,472 5,281,533
Operating income (loss) (1,745,943) (587,430)
Interest income 108,113 168,205
Interest Expense 22,596 17,407
Total assets 4,966,577 8,092,663
Property additions 13,484 25,740
Depreciation, Depletion and Amortization, Nonproduction $ 23,113 $ 20,762